AI has been hyped as a revolutionary technology for life sciences and healthcare. Is it really having an impact? It is still relatively early days but we think it is …. but how can we be surefooted on next steps?
How will Brexit impact medical device regulation? Will this add barriers to approval, investment and ultimately patient access? Can new regulations create more opportunities?
This year’s conference themes were detection, reflection, and projection. Speakers focused on the sector’s response to the pandemic, lessons learned, and what this means for the future of MedTech.
For many years, medical devices played second fiddle to medicines in the pharmaceutical industry. Their role was to facilitate the use of the “star” products, the drugs.
During our careers, the opportunity to work on something genuinely ground-breaking, something pioneering that raises the bar, is extremely rare.
Download the new health and life sciences report now for insights on the future of HLS, compliant commerce, and why embracing digital patient engagement solutions is the key to driving loyalty, brand valuation, and revenue through COVID-19 and beyond